PSR Orphan Experts - now Ergomed

12/04/2021

We’ve moved! PSR Orphan Experts is now Ergomed. To stay updated on future news, please follow us on the Ergomed page at https://www.facebook.com/ergomedplc

By aligning our CRO brands with a cohesive scope of leading industry expertise in both oncology and rare disease drug development, we are bettering our support to our clients as a unified, global specialty provider.

For more information, please visit: https://www.ergomedplc.com/medsource-and-psr-orphan-experts-rebrand-to-ergomed/

08/03/2021

Today is a day to celebrate women's achievements.
At PSR Orphan Experts, we are proud to state that the Ergomed Group has 76% of its workforce as women. 73% of our line managers are women.
Thank you for helping us thrive with your hard work and commitment.
We celebrate your achievements, and we will continue, as an organization, to promote a culture where women's careers and accomplishments are recognized.

Happy Women's Day!

28/02/2021

With over 300 million people currently estimated to be living with a Rare Disease, it questions the term “rare” and makes us even more proud to specialize in rare disease Clinical Research & Trial Development, Pharmacovigilance and Medical Information.

Today, in honor of Rare Disease Day, Ergomed offices have united around the world to raise global awareness for those impacted by rare diseases.

Watch our video below to see how we’ve supported virtually this year, and how you can join the fight by getting involved and making the promise!

With over 300 million people currently estimated to be living with a Rare Disease, it questions the term “rare” and makes us even more proud to specialize in...

24/02/2021

PSR Orphan Experts, as a subsidiary of ERGOMED PLC, is one of the very few companies exclusively focused on orphan disease drug development and recognized as a leading expert in assisting biotech and pharma companies in the rare disease niche. It is our mission to make a significant innovative contribution to the availability of new treatments for rare disease patients.
Did you know that there are over 300 million people living with a Rare Disease? All of us make the to raise global awareness for those impacted by a rare disease. Join us today!

12/01/2021

Our Ergomed employee stories continue! We are joined by Tonya who shares some insights on her role in Ergomed as a Data Manager / Central Monitor, what aspec...

05/01/2021

NEWS: Please join us for our first 2021 PrimeVigilance free learning webinar, which is open for registration with the topic "The Impact of Brexit on Pharmacovigilance," to occur on January 28, 2021.

In this webinar, our expert speakers Dr. Marcela Fialova and Dr. Jana Hyankova will present and provide our listeners with a good understanding of Brexit's impact on the EU and the UK pharmacovigilance processes, highlighting the challenges for the Pharmaceutical Industry and the critical requirements that could arise.

This webinar will run in 2 sessions:
• Session 1: 28 January, 10am EST / 3pm GMT / 4pm CET
• Session 2: 28 January, 2pm EST / 7pm GMT / 8pm CET

To register for one of the sessions, please click directly on https://bit.ly/PVL-Webinar-Brexit-Register

And for more information, please visit our website http://bit.ly/pv-brexit-webinar

18/12/2020

Season's Greetings from all of us at PSR.

We would like to extend our very best wishes to everyone for the new year and to express our appreciation and gratitude to all our clients, colleagues, and partners.

We look forward to 2021!

#2021

14/12/2020

News: PSR Orphan Experts, as part of Ergomed plc, is delighted to share the exciting news about Ergomed’s acquisition of MedSource, a US-based CRO specializing in oncology and rare disease, complementary to Ergomed core focus areas.

Ergomed looks forward to working with the MedSource team to leverage combined expertise in problematic therapeutic areas to benefit clients worldwide.

For more information please visit https://bit.ly/3alyVDt

02/12/2020

As part of the Ergomed group, we are delighted to share the link to the latest Pharmafile.com Autumn 2020 edition featuring Ergomed plc Patient Engagement Officer, Bojana Mirosavljevic and her inspiring story about her heartbreaking personal experience with rare disease, the passing of Zoya's law in Serbia, and the importance of a patient-centric approach in clinical trials for rare disease patients.

To read the full article on pages 42-44 visit https://bit.ly/37oMoHu.